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Introduction
Today, endoscopic mucosal resection (EMR) is a well-estab-
lished and widely accepted resection technique for colorectal
adenomas [1]. The major disadvantage is an increased risk of
recurrence when endoscopic resection (ER) has to be per-
formed piecemeal in lesions exceeding 20mm in diameter.
Endoscopic submucosal dissection (ESD) allows en bloc resec-
tion regardless of a lesion’s size, leading to a minimized recur-
rence risk [2]. However, ESD is technically difficult, time-con-
suming and there is a learning curve especially for western
endoscopists [3–4]. Western data on colorectal ESD are limited
and the role of ESD for colorectal lesions is, at present, not well
defined.
When rectal neoplasia extends to the dentate line (RNDL), ER
involves specific difficulties. In comparison to the proximal rec-
tum and the colon, risk for bleeding and pain may be higher due
to presence of rectal venous plexus and sensory nerves in the
squamous epithelium of the anal canal. Furthermore, direct
drainage into the systemic circulation can increase risk of bac-
teremia. Beyond these anatomical characteristics, the narrow
lumen and vicinity of the anal sphincter increase the technical
difficulties including poor maneuverability and reduced visuali-
zation of the resection field. Today, data on ER in RNDL are lim-
ited and current guidelines give no specific recommendations
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Background and study aims The ideal treatment strate-
gy for rectal neoplasia extending to the dentate line
(RNDL) is not well defined. Endoscopic mucosal resection
(EMR) and submucosal dissection (ESD) compete with sur-
gical techniques such as transanal endoscopic microsur-
gery (TEM). Non-Asian data and prospective data on ESD
are lacking. The study aim was to evaluate the role of ESD
in treatment of RNDL in a Western center.
Patients and methods Eighty-six patients with rectal
adenomas were included. ESD was performed in 86 rectal
adenomas including 24 RNDLs (27.9%) and 62 lesions dis-
tant from the dentate line (72.1%).
Results En bloc resection rate was comparable (91.7% vs.
93.5%, P=0.670) between ESD for RNDL and non-RNDL.
R0 resection rate was significantly lower in ESD for RNDL
compared to that for non-RNDL (70.8% vs 88.7%; P=
0.039), but most non-R0 resection was unclear margin
(Rx) and was not obvious positive margin (R1). Accordingly,
the recurrence rate after ESD for RNDL (4.5%) was not sta-
tistically different from that for non-RNDL (0%, P=0.275)
and was lower than that previously reported for EMR. Medi-
an procedure time was 127 vs. 110 minutes (P=0.182). Risk
of delayed bleeding (20.8% vs. 0%, P=0.001) and postinter-
ventional pain (33.3% vs. 14.5%, P=0.07) increased in
RNDL cases, but they were managed conservatively. Inci-
dence of stricture (4.2% vs. 1.6%, P=0.483) and perfora-
tion (0% vs. 1.6%, P=1.000) were similar.
Conclusions ESD is a feasible and safe resection technique
for RNDLs. A randomized controlled trial comparing ESD to
other methods (EMR or transanal surgery) is warranted.
Original article
Probst Andreas et al. Endoscopic submucosal dissection… Endoscopy International Open 2018; 06: E1355–E1362 E1355
on the ideal treatment strategy (EMR, ESD, transanal surgery)
[5–6].
The aim of this study was to analyze the efficacy and safety
of ESD in RNDLs in a European center beyond the learning
curve.
Patients and methods
The study was conducted as a single-center uncontrolled study
in a German referral center (Department of Gastroenterology,
Klinikum Augsburg, Germany). Patients were included in the
German ESD registry which was approved by the ethics com-
mittee of the Ludwig-Maximilians-University Munich, Germany.
Data were collected prospectively within this registry and ana-
lyzed retrospectively. At the beginning of the study, ESD was
standard treatment for rectal neoplasia in our department as
reported previously [7]. Patients were included from June
2016 to February 2018.
Inclusion criteria for ESD




▪ American Society of Anesthesiologists (ASA) Score I-III
▪ Written informed consent to participate in the German ESD
registry
▪ Written informed consent for the ESD procedure after pa-
tients received detailed information about ESD and alterna-
tive treatment options (EMR, transanal surgery).
Exclusion criteria for ESD
▪ Suspected invasion into or beyond the deep submucosal
layer after diagnostic workup (≥T1sm3 carcinoma)
▪ Biopsies showing submucosal invasive cancer
▪ Circumferential lesions
▪ Pretreated lesions with complete non-lifting
▪ Submucosal lesions
▪ Concomitant malignant disease without curative treatment
option
Secondary exclusion after ESD
▪ Histopathological diagnosis of submucosal invasive cancer
(SMIC)
Outcome criteria
Measured outcome parameters were procedural success (R0 re-
section rate, recurrence rate) and safety (complications).
Diagnostic workup
Video endoscopy with white light (WLE) and narrow band ima-
ging (NBI) was performed with a videogastroscope (GIF-
HQ190; Olympus Medical Systems, Tokyo, Japan).
Lesions were classified according to the Paris classification
and the classification of laterally spreading tumors (LST) [8–
9]. When SMIC was suspected by morphological criteria (Paris
type 0-Is, 0-Is-IIc, 0-IIa-Is, 0-IIa-IIc and/or nongranular type le-
sions with depressed morphology), biopsies were taken and
endoscopic ultrasound (EUS) was performed to rule out ad-
vanced cancer (> T1) and LNM. When cancer was confirmed in
a biopsy, staging was completed with additional magnetic res-
onance imaging of the rectum and computed tomography scan
of the chest and abdomen. After the diagnostic workup, ESD
was performed. When submucosal invasive cancer was shown
in biopsies or advanced cancer (> T1) was suspected, ER was
not performed and surgical resection was recommended. In le-
sions appearing benign by macroscopic criteria, EUS was not
performed and biopsies were not taken prior to ER.
ESD procedure and follow-up
A videogastroscope (GIF-HQ190, Olympus Medical Systems,
Tokyo, Japan) with a transparent cap (D-201-11804, Olympus)
at the tip of the scope and insufflation with carbon dioxide was
used for ESD. The standard solution for submucosal injection
was a mixture of saline, epinephrine (1:100.000), glycerol
(10%), and a slight amount of indigo-carmine. Local anesthetics
were not used for injection. During and after completed ESD,
large visible vessels or bleeding sites were coagulated with the
Coagrasper (FD-410 LR, Olympus). Antibiotics were adminis-
tered individually depending on the endoscopist’s decision. A
VIO 300D electrosurgical generator (ERBE Elektromedizin, Tü-
bingen, Germany) was used (endo cut I mode 60−80W for cut-
ting and spray coag mode 60W for coagulation). Mucosal inci-
sion and submucosal dissection were performed with the hook-
knife (KD-620LR; Olympus).
ESD was performed in a standardized way starting with in-
jection, mucosal incision, and submucosal dissection at the le-
sion’s distal margin (forward view). Afterward, mucosal incision
was completed circumferentially (retroflexed view) and submu-
cosal dissection was completed in forward and retroflexed posi-
tion. In lesions exceeding 30% to 40% of the circumference, a
submucosal tunnel was created in the middle of the resection
area after circumferential incision and dissection was comple-
ted towards the lateral margins afterwards. An ESD procedure
is shown in ▶Fig. 1. Sedation with midazolam, pethidine and
propofol was administered by a second physician, under contin-
uous cardiorespiratory monitoring. Patients stayed in the hos-
pital for 48 to 96 hours after ESD. Routine control endoscopies
were not performed. An equal number of ESD procedures were
performed by three endoscopists experienced in rectal ESD
(A. P., A. E., H.M.). Each endoscopist had performed 50 to 200
rectal ESDs prior to the study. Anticoagulants except aspirin
had been stopped before ESD and were restarted 5 to 7 days
after the procedure depending on the endoscopist’s decision.
During the hospital stay, the patient’s body temperature was
taken twice daily. When it exceeded 38° C, antibiotics were
started intravenously (ceftriaxone 2g once daily and metroni-
dazole 0.5 g every 8 hours). Patients were questioned three
times a day about postinterventional pain, and analgetics were
offered on demand at any time (metamizole, acetaminophen).
When SMIC was diagnosed in the specimen, the further
treatment strategy (follow-up versus surgery) was discussed in
an interdisciplinary board of gastroenterologists and surgeons.
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Follow-up endoscopy was performed 4 to 6 months after
ESD with a videogastroscope (GIF-HQ190, Olympus Medical
Systems, Tokyo, Japan) with a transparent cap using WLE and
NBI. Biopsies were taken when residual neoplasia was suspect-
ed. When recurrence was diagnosed, endoscopic retreatment
was performed and another follow-up endoscopy was sched-
uled 3 months later. When recurrence was ruled out, follow-up
endoscopy was scheduled 1 year later. Follow-up recommenda-
tion was given according to a local protocol.
Histopathologic workup
ESD specimens were fixed on cork with needles. Specimen size
was measured and specimens were sent for histopathological
assessment. The specimens were cut into parallel sections of
3-mm thickness or less and completely embedded in paraffin
in an oriented fashion. Intramucosal lesions were classified as
adenoma with low-grade or high-grade intraepithelial neopla-
sia (LGIEN, HGIEN). R0 or R1 was described for the vertical mar-
gin (VM) and the horizontal margin (HM).
Complications
Complications were defined as bleeding, perforation, stenosis
or death. Bleeding during ESD was considered as a complication
when it was severe, leading to premature termination of ER.
Delayed bleeding was defined as when clinical bleeding signs
were observed after ESD (rectal bleeding or hemoglobin drop
>2g/L) [10]. In these cases, endoscopic treatment was per-
formed. Perforation was defined as an obvious endoscopic
view into the perirectal space or the peritoneal cavity. Stenosis
was considered as a complication when it was symptomatic.
Complications were classified according to the Common Termi-
nology Criteria for Adverse Events (CTCAE) Version 4.0.
Statistical analysis
Depending on the number of groups, a Mann-Whitney Rank
Sum test or a Kruskal-Wallis One Way Analysis of Variance on
Ranks was used to compare numeric values. For the compari-
son of categorical data, a Chi Square or Fisher Exact test was
employed, depending on the expected frequency of the obser-
vations. P values < 0.05 were considered statistically significant.
Calculations were performed using the software package Sig-
ma Plot 13.0 (Systat Software, San Jose, California, United
States).
Results
Patient and lesion characteristics
Over a 17-month-period, 112 patients referred for ER of rectal
neoplasia were enrolled (60% men; median age 64.0 y, range
36−86 y). After exclusion of 11 patients (9.8%), ESD was per-
formed in 101 patients (90.2%). ▶Fig. 2 gives an overview of
the study population. Histopathology revealed SMIC in 15 of
the resected lesions (14.9%). Nine of them underwent addi-
tional surgery (6 patients with deep invasion making comple-
tion of en bloc resection impossible and leading to piecemeal
resection and another 3 patients with R0 resection but submu-
cosal invasion exceeding 1000µm in the ESD specimen). Surgi-
cal specimens showed one pT2pN0 and another pT2pN1 cancer
while seven specimens did not show residual cancer or lymph
node metastasis. Six patients underwent follow-up after ESD
▶ Fig. 1 ESD of a granular-type LST extending to the dentate line (Paris type 0-IIa + Is). a Retroflexed view after marking the resection borders
using hook-knife. b Mucosal incision of the squamous epithelium in the anal canal (forward view). c Retroflexed view after completion of the
mucosal incision. d Retroflexed view after completion of ESD. e Distal resection margin including hemorrhoids after completion of ESD (for-
ward view). f Resection specimen (diameter 115×50mm; area 45.1 cm2). g Histopathologic assessment showing adenoma with focal HGIEN
resected R0 (H&E, scanning magnification). h Distal resection margin showing R0 resection within the squamous epithelium and thick vessels
resected from the rectal venous plexus (H&E, scanning magnification).
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of pT1 cancers with submucosal invasion≤1000µm and did not
show recurrence during follow-up.None of the SMICs had ex-
tended to the dentate line. To make the groups comparable for
follow-up and especially regarding recurrences, SMICs were ex-
cluded from further analysis.
Eighty-six benign lesions were included for further analysis.
Twenty-four lesions extended to the dentate line (27.9%) while
62 lesions did not reach the squamous epithelium of the anal
canal (72.1%). Female sex was higher in the RNDL group
(54.2% versus 32.3%; P=0.104). Both groups were comparable
regarding patient age, ASA status, lesion size, lesion morpholo-
gy and proportion of pretreated lesions. Paris type 0-IIa + Is
(granular type LST with nodules) was the most frequent lesion
type (73.3%). Fourteen of 24 lesions (58.3%) involving the den-
tate line were located on hemorrhoids. Lesion size was calculat-
ed as the surface of an ellipse by using the long and the short
diameter of the resection specimen; using only the largest
diameter would not describe lesion size correctly, especially in
RNDLs lesions which have an oval shape in most cases
(▶Fig.1f). Patient and lesion characteristics are shown in ▶Ta-
ble1.
Procedure characteristics
▶Table2 shows procedure characteristics. Median procedure
time was 119 minutes and median resection speed was 6.9
minutes/cm2. Both parameters did not differ significantly be-
tween RNDL lesions and proximal lesions. The en bloc resection
rate was comparable (91.7% versus 93.5%; P=0.670) while the
R0 resection rate was significantly lower after ESD for RNDLs
(70.8% versus 88.7%; P=0.039). After en bloc resection, five
RNDL and three proximal lesions were judged R1/Rx at the
HM. R1 resection at the HM was not observed in any lesion.
When R0 resection could not be confirmed in RNDL specimens,
the reason was R1/Rx within the squamous epithelium in two
patients. In another two patients, non-neoplastic squamous
epithelium was not found in the specimen while the margins
showing R0 resection showed non-neoplastic rectal epithelium.
In one patient, R1 was diagnosed within the rectal mucosa only.
Recurrence rate was 1.2% (1/80) after en bloc resection and
66.7% (4/6) after piecemeal resection. Recurrences were small
(< 5mm in diameter) and were treated with forceps biopsy in
four cases and with additional APC in one case. One patient
with a small recurrence underwent surgery because of sympto-
matic stenosis of the proximal rectum.
Complications
Delayed bleeding occurred in five of 24 lesions (20.8%) after
ESD for RNDL and in none of the lesions that did not reach the
dentate line (P=0.001). In three patients, bleeding was treated
with endoscopic clipping (Days 1, 2 and 12 after ESD). Coagula-
tion of visible vessels was performed in the remaining two
(Days 1 and 4). Blood transfusion was not required in any pa-
tient. None of the patients took anticoagulants at the time of
the bleeding. Perforation was diagnosed during ER of a 50-mm
LST 12cm from the dentate line. Perforation was caused by
snare resection when ESD had been switched to EMR because
of poor maneuverability of the scope. An over-the-scope clip
(OTSC, OVESCO, Tübingen, Germany) was used and antibiotics
were administered. The further course was uneventful and the
patient was discharged 48 hours later.
One patient developed rectal stenosis 2 months after ESD of
a granular-type LST reaching the dentate line for 75% of the cir-
cumference, resulting in a resection ulcer of 90% of the circum-
ference. Balloon dilatation was performed once and further fol-
low-up over 10 months was uneventful. Another stenosis was
diagnosed 2 months after circumferential ER of a recurrent LST
after previous EMR. The lesion was located 12 cm from the anal
verge and ESD had been switched to EMR because of severe
submucosal fibrosis and poor maneuverability of the scope.
After two sessions of balloon dilatation, recurrent adenoma
was diagnosed within the stenosis 3 months after ER and the
patient preferred surgical treatment. Transabdominal resection
with temporary ileostomy was performed.
Antibiotics were administered in a prophylactic approach in
30 of 86 patients (34.9%) (41.7% in the RNDL group versus
32.3% after ER of proximal lesions; P=0.656). Six of 56 patients
(10.7%) without prophylactic antibiotics developed fever
(>38 °C) on the day of or after the procedure. Antibiotics were
started when fever was observed and continued for 72 hours.
Fever was seen also in three of 30 patients who had received
prophylactic antibiotics (10.0%). Temperature normalized
within 48 hours in all patients.
Of the patients, 19.8% reported pain and accepted metami-
zole or acetaminophen within 48 hours after ER. Need for anal-
Neoplastic rectal lesions referred for ESD n = 112
Lesions treated with ESD n = 101
Benign lesion n = 86
▪ Adenoma with LGIEN
 n = 29
▪ Adenoma with HGIEN
 n = 57
Submucosal invasive 
cancer n = 15
▪ Low-risk criteria n = 6
▪ High-risk criteria n = 9
Extending to the dentate 
line n = 24
Distant from the dentate 
line n = 62
Excluded prior to resection (referred for surgical 
resection) n = 11
▪ Advanced malignancy suspected n = 6
 (surgery n = 5: pT1 high-risk n = 1, pT3 n = 2,
 HGIEN n = 2, treatment refused n = 1)
▪ Circumferential lesion n = 2
 (surgery n = 2: HGIEN n = 2)
▪ Non-lifting scar after repeated pretreatment n = 3        
 (surgery refused n=3: treatment with EMR and
 APC)
▶ Fig. 2 Overview of the study population.
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getics was higher in the RNDL group; because of small patient
numbers, the difference was not statistically significant (33.3%
vs. 14.5%; P=0.07). At discharge, none of the patients needed
further analgetics. Adverse events and their CTCAE grading are
summarized in ▶Table3.
Discussion
Screening colonoscopies have been introduced in several coun-
tries over the last decades and could be shown to be effective in
detecting premalignant adenomas and CRCs at an earlier stage.
ER of benign adenomas prevents the incidence and reduces the
mortality of colorectal cancer (CRC) [11]. However, ER becomes
difficult and shows an increased risk of incomplete resection
and recurrence when lesions are large (≥40mm) or located
close to the ileocecal valve, appendiceal orifice or dentate line
[12]. For rectal neoplasia extending to the dentate line (RNDL),
endoscopic resection techniques compete with transanal sur-
gery. Randomized studies are lacking and the optimal treat-
ment strategy is not well defined.
ER at the dentate line contains specific difficulties related to
the anatomical features of the anal canal. In contrast to the
proximal rectum scope, maneuverability is limited and visuali-
zation of the resection field is reduced. Moreover, risk for
bleeding and pain might be increased due to presence of the
rectal venous plexus and the sensory nerves in the squamous
epithelium of the anal canal.
ESD can achieve high rates of en bloc resection and R0 resec-
tion regardless of lesion size, leading to minimization of risk of
recurrence [2, 7]. Another advantage is the possibility of inject-
▶ Table 2 Procedure characteristics and recurrences.























































▶ Table 1 Patient and lesion characteristics.
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ASA grade 1/2/3 54/30/2 12/11/ 1 42/19/1 0.287

















Paris classification 0-Is/0-IIa/0-IIa + Is/0-IIa + Iic









Histology LGIEN/HGIEN 29/57 12/12 17/45 0.083
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ing, cutting and coagulating very precisely and very close to the
mucosa even in areas with poor maneuverability such as the
anal canal. When ESD was not available, RNDL were treated sur-
gically in most cases and only two small studies report exist on
conventional EMR for such lesions. As reported from large EMR
studies for colorectal neoplasia, these studies confirmed tech-
nical success with and safety of EMR but also a substantial re-
currence risk of 22.2% and 18.4%, respectively [13, 14]. Holt et
al. included 24 lesions involving the anorectal junction, which
was defined as “involving the dentate line or lying within 2 cm
of the dentate line” [13]. Liu et al included 49 lesions but only
24 of them showed a distance of less than 1 cm to the dentate
line [14]. For interpretation of EMR data of RNDL, these inclu-
sion criteria have to be taken into account and EMR might be
even more difficult or impossible when involvement of the den-
tate line is extensive. Meanwhile, retrospective Asian studies re-
ported on ESD for RNDL showing en bloc-resection rates ex-
ceeding 90% and a recurrence rate of 0% in most reports [15–
19]. Prospective data and Western data on ESD for RNDL are not
available so far. ▶Table 4 summarizes published studies on
endoscopic treatment of RNDL.
In our study 86 patients with large rectal adenomas were
treated with ESD. A substantial proportion (27.9%) extended
to the dentate line. Only lesions reaching the squamous epithe-
lium were judged RNDL, which makes a comparison to pub-
lished EMR data difficult.
As reported in nearly all studies on ER in RNDL and in con-
trast to studies including all colorectal neoplasia, a predomi-
nance of the female sex was seen in RNDL (54.2%). In accord-
ance with published data, we could confirm high en bloc resec-
tion for both RNDL and proximal rectal lesions (91.7% vs.
93.5 %, P=0.670). R0 resection was significantly lower after
ESD for RNDL (70.8% vs 88.7%; P=0.039). Despite the reduced
R0 resection rate, the recurrence rate was low in the RNDL
group and only one recurrence was observed after en bloc re-
section of RNDL (4.5%). A decreased R0 resection rate of only
53.3% after ESD for RNDL without an increase in the recurrence
rate was also described by Imai et al. previously [16]. One rea-
son might be thermal damage to the resection specimen at the
distal margin within the squamous epithelium. This hypothesis
is supported by findings from our study when R1/Rx resection
was located within the squamous epithelium in 80% and within
the rectal mucosa in only 20%. Due to the narrow space of the
anal canal, a wide distance between the mucosal incision and
the lesions margin cannot be achieved and risk for coagulation
of lesion margins might be also increased during dissection.
Close follow-up seems adequate after R1 /Rx resection of ER in
RNDL. Procedure time in our study was comparable with Asian
data reporting median procedure times of 99 to 127 minutes
[15–19].
Major concerns in ER close to the dentate line are risks for
pain, bleeding, and bacteremia. In 2011, Sanchez-Yague et al.
proposed injection of lidocaine to reduce intraprocedural and
postprocedural pain [20]. Despite lack of data on the pain rate
without injection of anesthetics and lack of further data, all
Asian studies followed this regimen and reported postinterven-
tional pain in 17.2% to 33.3% of cases. To avoid potential side
effects after intravascular injection, we used injection fluid
without local anesthetics in our study and observed pain in
33.3% of cases after ESD for RNDL but also in 14.5% after ESD
distant from the dentate line. The theoretical benefit of local
anesthetics is not well demonstrated today. It should be further
investigated and a randomized study would be desirable. Asian
authors report delayed bleeding in 0% to 28.6% of cases. We
confirmed a significant increase in delayed bleeding after ESD
of RNDL but endoscopic treatment was always possible (20.8%
vs. 0%; P=0.001). The role of antibiotic prophylaxis to prevent
fever and infection was unclear when we started our study. Imai
et al. had reported a 22.2% rate of high-grade fever after ESD of
RNDL but other authors did not report on this [16]. In our study,
▶ Table 3 Complications of ESD in rectal neoplasia.
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CTCAE, Common Terminology Criteria of Adverse Events (version 4.0)
E1360 Probst Andreas et al. Endoscopic submucosal dissection… Endoscopy International Open 2018; 06: E1355–E1362
Original article
antibiotics were administered individually depending on the
endoscopist’s decision. High-grade fever occurred in 10.6% of
patients who had received prophylactic antibiotics and in 10%
of patients who had not received the drugs. Severe infections
were not observed. Due to non-randomization we cannot draw
a conclusion from these observations. Recently, Lee et al. dem-
onstrated a significant reduction in post-ESD electrocoagula-
tion syndrome after use of prophylactic antibiotics in a random-
ized study [21]. In accordance with these data, we would re-
commend prophylactic antibiotics for all colorectal ESDs in the
future.
ER of RNDL competes with surgical resection techniques
such as transanal full-thickness-resection and transanal endo-
scopic microsurgery (TEM). Recently, a randomized study failed
to demonstrate non-inferiority of conventional EMR in compar-
ison to TEM. Recurrence rates were 15% after EMR and 11%
after TEM. Median procedure times were 53 minutes and 60
minutes, respectively. Specific analysis of RNDL was not includ-
ed [22]. Randomized prospective studies comparing ESD and
surgery are lacking.
Conclusions
ESD is a feasible and safe resection technique for RNDL. The re-
currence rate is lower than that previously reported for EMR
and TEM. Rates of delayed bleeding and postinterventional
pain are increased in RNDL but complications can be managed
conservatively.
Limitations of this study are the small number of patients
and lack of a control group. Randomized controlled trials com-
paring ESD to other resection techniques (EMR or transanal sur-
gery) are needed to define the ideal treatment strategy for
RNDL.
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Recurrence 22.2% 18.4% 0 0 0 0 N/A 4.5%
N/A, not available
1 Lesions involved the dentate line or were lying within 2 cm of the dentate line
2 24 lesions (49%) were located 0 to 1.0 cm from the dentate while 25 (51%) were located 1.1 to 2.0 cm from the dentate line
3 All lesions involved the dentate line




[1] Moss A, Williams SJ, Hourigan LF et al. Long-term adenoma recur-
rence following wide-field endoscopic mucosal resection (WF-EMR)
for advanced colonic mucosal neoplasia is infrequent: results and risk
factors in 1000 cases from the Australian Colonic EMR (ACE) study.
Gut 2015; 64: 57–65
[2] Saito Y, Fukuzawa M, Matsuda T et al. Clinical outcome of endoscopic
submucosal dissection versus endoscopic mucosal resection of large
colorectal tumors determined by curative resection. Surg Endosc
2010; 24: 343–352
[3] Probst A, Golger D, Arnholdt H et al. Endoscopic submucosal dissec-
tion of early cancers, flat adenomas and submucosal tumors in the
gastrointestinal tract. Clin Gastroenterol Hepatol 2009; 7: 149–155
[4] Probst A, Golger D, Anthuber M et al. Endoscopic submucosal dissec-
tion of large sessile lesions of the rectosigmoid: learning curve in a
European center. Endoscopy 2012; 44: 660–667
[5] Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al. Endoscopic Sub-
mucosal Dissection: European Society of Gastrointestinal Endoscopy
(ESGE) Guideline. Endoscopy 2015; 47: 829–854
[6] Rutter MD, Chattree A, Barbour JA et al. British Society of Gastroen-
terology/Association of Coloproctologists of Great Britain and Ireland
guidelines for the management of large non-pedunculated colorectal
polyps. Gut 2015; 64: 1847–1873
[7] Probst A, Ebigbo A, Märkl B et al. Endoscopic submucosal dissection
for early rectal neoplasia: experience from a European center. Endos-
copy 2017; 49: 222–232
[8] Endoscopic ClassificationReview Group. Update on the Paris Classifi-
cation of Superficial Neoplastic Lesions in the Digestive Tract. Endos-
copy 2005; 37: 570–578
[9] Kudo S, Lambert R, Allen JI et al. Nonpolypoid neoplastic lesions of the
colorectal mucosa. Gastrointest Endosc 2008; 68: S3– S47
[10] Cotton PB, Eisen GM, Aabakken L et al. A lexicon for endoscopic ad-
verse events: report of an ASGE workshop. Gastrointest Endosc 2010;
71: 446–454
[11] Zauber AG, Winawer SJ, OʼBrien MJ et al. Colonoscopy polypectomy
and long-term prevention of colorectal-cancer deaths. N Engl J Med
2012; 366: 687–696
[12] Rutter MD, Chattree A, Barbour JA et al. British Society of Gastroen-
terology/Association of Coloproctologists of Great Britain and Ireland
guidelines for the management of large non-pedunculated colorectal
polyps. Gut 2015; 64: 1847–1873
[13] Holt BA, Bassan MS, Sexton A et al. Advanced mucosal neoplasia of
the anorectal junction: endoscopic resection technique and out-
comes (with videos). Gastrointest Endosc 2014; 79: 119–126
[14] Liu S, Li Y, Yang H et al. Retroflexion-assisted endoscopic mucosal re-
section: a useful and safe method for removal of low rectal laterally
spreading tumors. Surg Endosc 2016; 30: 139–146
[15] Nakadoi K, Tanaka S, Hayashi N et al. Clinical outcomes of endoscopic
submucosal dissection for rectal tumor close to the dentate line.
Gastrointest Endosc 2012; 76: 444–450
[16] Imai K, Hotta K, Yamaguchi Y et al. Safety and efficacy of endoscopic
submucosal dissection of rectal tumors extending to the dentate line.
Endoscopy 2015; 47: 529–532
[17] Tamaru Y, Oka S, Tanaka S et al. Endoscopic submucosal dissection
for anorectal tumor with hemorrhoids close to the dentate line: a
multicenter study of Hiroshima GI Endoscopy Study Group. Surg En-
dosc 2016; 30: 4425–4431
[18] Tanaka S, Toyonaga T, Morita Y et al. Feasibility and safety of endo-
scopic submucosal dissection for lower rectal tumors with hemor-
rhoids. World J Gastroenterol 2016; 22: 6268–6275
[19] Matsumoto S, Mashima H. The efficacy of endoscopic submucosal
dissection for colorectal tumors extending to the dentate line. Int J
Colorectal Dis 2017; 32: 831–837
[20] Sanchez-Yague A, Yamaguchi Y, Takao T et al. Endoscopic submucosal
dissection of a lower rectal polyp proximal to the dentate line by using
local lidocaine injection. Gastrointest Endosc 2011; 73: 405–407
[21] Lee SP, Sung IK, Kim JH et al. A randomized controlled trial of prophy-
lactic antibiotics in the prevention of electrocoagulation syndrome
after colorectal endoscopic submucosal dissection. Gastrointest En-
dosc 2017; 86: 349–357
[22] Barendse RM, Musters GD, de Graaf EJR et al. Randomised controlled
trial of transanal endoscopic microsurgery versus endoscopic muco-
sal resection for large rectal adenomas (TREND Study). Gut 2017; 67:
837–846
E1362 Probst Andreas et al. Endoscopic submucosal dissection… Endoscopy International Open 2018; 06: E1355–E1362
Original article
